Skip to main content

Table 1 Histological diagnoses and HPV status of women (Histologically confirmed cohort [N = 106])

From: Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka

Histological diagnosis

HPV status

n

Percentage

95% CI (LL–UL)

All ICC n' = 98

HPV +

83

84.7

(76.0–91.2)

Single infection

82

98.8

(93.5–100.0)

Multiple infection

1

1.2

(0.0–6.5)

SCC n’ = 80

HPV +

72

90.0

(81.2–95.6)

Single infection

71

98.6

(92.5–100.0)

Multiple infection

1

1.4

(0.0–7.5)

ADC n’ = 12

HPV +

6

50.0

(21.1–78.9)

Single infection

6

100.0

(54.1–100.0)

ASC n’ = 1

HPV -

1

100.0

(2.5–100.0)

UDC n’ = 1

HPV +

1

100.0

(2.5–100.0)

Single infection

1

100.0

(2.5–100.0)

ON n’ = 1

HPV +

1

100.0

(2.5–100.0)

Single infection

1

100.0

(2.5–100.0)

MIC n’ = 2

HPV +

2

100.0

(15.8–100.0)

Single infection

2

100.0

(15.8–100.0)

AIS n’ = 1

HPV +

1

100.0

(2.5–100.0)

Single infection

1

100.0

(2.5–100.0)

CIN 2/3 n’ = 8

HPV +

8

100.0

(63.1–100.0)

Single infection

8

100.0

(63.1–100.0)

  1. N: Total number of women in the histologically confirmed cohort. n: Number of women in each category. n’: Number of women by histological diagnosis. HPV+: Prevalence of HPV infection. HPV-: HPV infection not present. 95% CI: 95% confidence intervals. LL: Lower limit. UL: Upper limit. ICC, invasive cervical cancer; SCC, squamous cell carcinoma; ADC, adenocarcinoma; ASC, adenosquamous carcinoma; UDC, undifferentiated carcinoma; ON, other invasive neoplasm; AIS, adenocarcinoma in situ; MIC, microinvasive carcinoma; CIN, cervical intraepithelial neoplasia.